Dupixent® (Dupilumab) Recommended for EU Approval by the Chmp to Treat Eosinophilic Esophagitis (Eoe) in Children as Young as 1 Year Old
Dupixent® (Dupilumab)獲得了歐盟CHMP推薦,用於治療兒童食道嗜酸性粒細胞性食道炎(EoE),年齡最小可至1歲
Dupixent® (Dupilumab) Recommended for EU Approval by the Chmp to Treat Eosinophilic Esophagitis (Eoe) in Children as Young as 1 Year Old
Dupixent® (Dupilumab)獲得了歐盟CHMP推薦,用於治療兒童食道嗜酸性粒細胞性食道炎(EoE),年齡最小可至1歲
譯文內容由第三人軟體翻譯。